Atara BiotherapeuticsATRA
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 41 institutions reported holding Atara Biotherapeutics Inc. (ATRA) in their 13F filings, up 7 from Q3 2024. 7 opened new positions and 3 sold out. The largest holders were EcoR1 Capital, LLC ($7.1M), Redmile Group, LLC ($5.9M) and Citadel Advisors ($3.6M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Atara Biotherapeutics Inc.
- CUSIP
- 046513206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $994K |
| Exits | 3 | $360K |
All 13F filers, Q3 2024 → Q4 2024: 182,161 shares bought and 230,224 shares sold, net −48,063 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 41 holders
| EcoR1 Capital, LLC | 0.28% | Add +13.5% | 532,134 | $7.1M |
| Redmile Group, LLC | 0.41% | Reduce -2.3% | 441,701 | $5.9M |
| Citadel Advisors | 0.00% | Add +2.6% | 267,353 | $3.6M |
| Bank of America Corp. | 0.00% | Add +0.8% | 205,170 | $2.7M |
| Vanguard Group Inc. | 0.00% | Reduce -1.1% | 178,782 | $2.4M |
| Vestal Point Capital, LP | 0.10% | Add +0.3% | 125,000 | $1.7M |
| Acadian Asset Management LLC | 0.00% | Reduce -3.6% | 124,473 | $1.7M |
| Tang Capital Management LLC | 0.07% | No change | 75,196 | $1.0M |
| Renaissance Technologies | 0.00% | Reduce -0.9% | 67,140 | $894K |
| BlackRock, Inc. | 0.00% | Reduce -0.2% | 60,846 | $810K |
| Geode Capital Management, LLC | 0.00% | Add +17.2% | 54,744 | $729K |
| Staley Capital Advisers Inc. | 0.03% | Add +25.0% | 50,000 | $666K |
| Morgan Stanley | 0.00% | Add +75.1% | 28,351 | $377K |
| FMR LLC | 0.00% | Add +6.5% | 26,699 | $355K |
| State Street Corp. | 0.00% | Add +13.0% | 25,253 | $336K |
| Marshall Wace, LLP | 0.00% | New | 24,958 | $332K |
| Birchview Capital, LP | 0.24% | New | 22,000 | $293K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 14,000 | $186K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 12,682 | $169K |
| Northern Trust Corp. | 0.00% | New | 11,170 | $149K |
| Millennium Management | 0.00% | Reduce -94.2% | 10,133 | $135K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 3,603 | $48K |
| SBI Securities Co., Ltd. | 0.00% | — | 1,416 | $19K |
| Wells Fargo & Company | 0.00% | Reduce -24.0% | 951 | $13K |
| UBS Group AG | 0.00% | Add +107.5% | 834 | $11K |
| Russell Investments Group, Ltd. | 0.00% | No change | 719 | $10K |
| Osaic Holdings, Inc. | 0.00% | Reduce -5.3% | 610 | $8K |
| Group One Trading LLC | 0.00% | No change | 394 | $5K |
| Lazard Asset Management LLC | 0.00% | Add +244.2% | 444 | $5K |
| R Squared Ltd | 0.00% | — | 240 | $3K |
| JPMorgan Chase & Co. | 0.00% | Reduce -84.2% | 216 | $3K |
| Jones Financial Companies LLLP | 0.00% | New | 203 | $3K |
| IFP Advisors, Inc | 0.00% | No change | 180 | $2K |
| Banque Transatlantique SA | 0.00% | — | 176 | $2K |
| Rhumbline Advisers | 0.00% | No change | 175 | $2K |
| Royal Bank of Canada | 0.00% | Add +388.2% | 83 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -90.7% | 70 | $932 |
| Point72 (DIFC) Ltd | 0.00% | New | 68 | $905 |
| BNP Paribas Financial Markets | 0.00% | Add +8.9% | 61 | $812 |
| GAMMA Investing LLC | 0.00% | No change | 56 | $745 |
| Citigroup Inc. | 0.00% | Reduce -75.0% | 2 | $27 |
"% of holder's portfolio" is ATRA's weight in each manager's 13F, not the share of Atara Biotherapeutics Inc. the manager owns.